Skip to main content

Accelerated market launch of MedEye, a plug-and-play medication safety solution

Objective

Medication errors occur daily and form a major burden to society. Medication errors often lead to adverse drug reactions, lengthened hospital stays, increased healthcare costs, and in the most severe cases, increased mortality. Medication errors pose a significant risk to the European population. It is estimated that 4,7 million Europeans are harmed by a medication error every year, which amounts to preventable healthcare costs in excess of €11 billion a year. Strikingly, around 50% of medication errors can be stopped at the patient’s bedside. MedEye is an innovative medication verification suite that scans, detects and verifies medication at the bedside. MedEye stops medication errors from taking place by verifying medication before it is administered to patients. MedEye has already been tested and validated in three Dutch hospitals with excellent results. In this project, activities will be performed to push MedEye onto the European market and facilitate its deployment on a large scale. MedEye will be integrated with IT systems that serve a major part of European medical centers. Developments will also be performed to enable the sale, deployment and support of MedEye through distributors. Two launching pilots will be performed to establish transnational proof of performance and cost-effectiveness, which will be instrumental in penetrating the European markets. Given the diversity of the European healthcare landscape, a thorough market research will be performed to gear the commercialization strategy towards individual countries. Together, the activities in this project will provide access to the main EU market and facilitate a wide deployment of MedEye throughout Europe.

Field of science

  • /social sciences/economics and business/business and management/commerce
  • /medical and health sciences/basic medicine/pharmacology and pharmacy/pharmaceutical drug

Call for proposal

H2020-FTIPilot-2016-1
See other projects for this call

Funding Scheme

IA - Innovation action

Coordinator

MINT SOLUTIONS HOLLAND B.V.
Address
Europalaan 6
5232 BC 'S-hertogenbosch
Netherlands
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 1 118 097

Participants (5)

PHARMAFORCE NV
Belgium
EU contribution
€ 376 140
Address
Poortakkerstraat 41G
9051 Sint Denijs Westrem Gent
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
UNIVERSITY OF DURHAM

Participation ended

United Kingdom
EU contribution
€ 31 750
Address
Stockton Road The Palatine Centre
DH1 3LE Durham
Activity type
Higher or Secondary Education Establishments
THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST
United Kingdom
EU contribution
€ 421 832
Address
Freeman Hospital, High Heaton
NE7 7DN Newcastle-upon-tyne
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
FEDERATION EUROPEENNE DES HOPITAUX ET DES SOINS DE SANTE
Belgium
EU contribution
€ 103 637
Address
Avenue Marnix 30/17
1000 Bruxelles
Activity type
Other
UNIVERSITY OF NEWCASTLE UPON TYNE
United Kingdom
EU contribution
€ 413 013
Address
Kings Gate
NE1 7RU Newcastle Upon Tyne
Activity type
Higher or Secondary Education Establishments